Nocardia keratitis Prajna Lalitha
Transcription
Nocardia keratitis Prajna Lalitha
CE: Namrta; ICU/334; Total nos of Pages: 6; ICU 334 Nocardia keratitis Prajna Lalitha Aravind Eye Hospital and Postgraduate Institute of Ophthalmology, No.1 Anna Nagar, Madurai, Tamil Nadu 625020, India Correspondence to Dr Prajna Lalitha, MD, DNB, Head, Department of Ocular Microbiology, Aravind Eye Hospital and Postgraduate Institute of Ophthalmology, No.1 Anna Nagar, Madurai, Tamil Nadu 625 020 India Tel: +91 452 4356100; fax: +91 452 2530984; e-mail: lalitha@aravind.org Current Opinion in Ophthalmology 2009, 20:000–000 Purpose of review Nocardia keratitis is a rarity in most parts of the world. If the diagnosis is timely, and appropriate treatment started, then the visual outcome is good. The purpose of this review is to discuss the recently published literature in relation to the epidemiology, cause, diagnosis, and therapy of Nocardia keratitis. Recent findings The incidence of Nocardia keratitis, although not well established, appears to be increasing with new species identified with newer molecular methods. The different species causing keratitis are Nocardia. arthritidis, N. neocaledoniensis, N. asiatica, N. asteroids type IV, N. brasiliensis, N. pseudobrasiliensis, N. cyriacigeorgica, N. farcinica, N. otitidiscaviarum, and N. transvalensis. Current therapies with fortified amikacin and newer fluoroquinolones are effective, provided the diagnosis has been made in good time. Ongoing research toward rapid diagnosis using various molecular techniques seems to be promising. Diagnostic microbiology laboratories need to be familiar with these organisms especially in endemic areas, and it is important for the clinician to notify the suspicion of such cases. Summary The current recommended treatment is amikacin, and with appropriate therapy, Nocardia keratitis resolves with scarring, with or without vascularization, resulting in good visual outcome. Keywords amikacin, antibiotics, clinical appearance, Nocardia keratitis, species Curr Opin Ophthalmol 20:000–000 ß 2009 Wolters Kluwer Health | Lippincott Williams & Wilkins 1040-8738 Introduction Nocardia are aerobic, branching, beaded filamentous bacilli with Gram stain variability and are often acid-fast positive. Although relatively uncommon, Nocardia are an important cause of keratitis [1,2,3,4,5]. A delay in diagnosis may occur because of its rarity and unfamiliarity. Microbiology of Nocardia The taxonomic history of the genus Nocardia is fraught with confusion and controversy. Edmond Nocard, a French veterinarian, was the first to isolate a filamentous aerobic organism from cattle with farcy in 1888. In 1889, the genus Nocardia was created by Trevisan, and the organism described by Nocard was named Nocardia farcinica. However, 80 years later, Nocard’s original isolate revealed two different filamentous organisms, one of which was Mycobacterium and the other was Nocardia. The cause of bovine farcy has been subsequently attributed to a Mycobacterium sp., not a Nocardia sp. It is probable that the original isolate was Mycobacterium farcinogenes. Nocardia asteroids is now accepted as the type 1040-8738 ß 2009 Wolters Kluwer Health | Lippincott Williams & Wilkins species of the genus Nocardia, and recently several investigations have contributed to the formation of a homogeneous group of Nocardia [6]. Brown-Elliott et al. [7] have recently reviewed the clinical and laboratory features of the Nocardia spp. based on current molecular taxonomy and found that there are currently more than 30 species of Nocardia of human clinical significance, with the majority of isolates being N. nova complex, N. abscessus, N. transvalensis complex, N. farcinica, N. asteroids type VI (N. cyriacigeorgica), and N. brasiliensis. These species cause a wide variety of diseases and have variable drug susceptibilities [7]. Identification Determination of the various species of Nocardia may be helpful to define the spectra of disease caused by the different species. Traditionally, Nocardia were identified to species by using a battery of biochemical tests, which included hydrolysis of adenine, casein, tyrosine, xanthine, and hypoxanthine [8]. Conventional methods of identification appear to be unreliable for species level identification of many species of Nocardia because of the small number of discriminatory tests available and the DOI:10.1097/ICU.0b013e32832c3bcc Copyright © Lippincott Williams & Wilkins. Unauthorized reproduction of this article is prohibited. CE: Namrta; ICU/334; Total nos of Pages: 6; ICU 334 2 Corneal and external disorders expertise needed to interpret these tests. Compared with these methods, molecular testing by hsp65 PCR and 16S restriction enzyme analysis (PCR-restriction enzyme analysis) appears to be an improvement and recognizes more than 90% of currently recognized clinical species [9–11]. Epidemiology There have been sporadic reports in the literature about the incidence of Nocardia keratitis. Upadhyay et al. [12] from Nepal reported that Nocardia constituted 0.3% of all bacterial isolates from cases of keratitis. A study [13] from Hyderabad in South India revealed that among 689 bacterial isolates from cases of keratitis examined between January 1991 and December 1998, Nocardia species constituted 1.7%. An earlier study [14] from our Institution reported that Nocardia constituted 4.2% of all culture positive bacterial cultures. Recently, in a review of culture-positive samples from bacterial keratitis, it was found that Nocardia was isolated from 8.34% of cases (95 cases out of 1139 in the years 2006–2008; unpublished data). This may indicate that the incidence may be increasing in this part of the world. Predisposing factors The usual predisposing factors are trauma, surgery, corticosteroid use, and contact lens wear. In a series of 16 cases from India, trauma was the inciting factor in 25% of cases [2]. The nature of traumatizing agents reported includes vegetative material, dirt, stone, gravel, and nail injury. Bharathi et al. [15] in their study from South India found that the majority of the patients had a history of trauma related to agricultural work. Yin et al. [19] assessed the hsp65 gene sequencing for detection and species identification of genus Nocardia from ocular isolates and found N. arthritidis, N. neocaledoniensis, N. asiatica, N. asteroids type IV, N. brasiliensis, and N. pseudobrasiliensis, and concluded that N. arthritidis is the most important causal species that causes Nocardia keratitis. In the study [3] published from our Institute, of 32 isolates the species identified were N. cyriacigeorgica (n ¼ 11, 34.37%), N. asteroids (n ¼ 9, 28%), N. farcinica (n ¼ 7, 22%), and N. otitidiscaviarum (n ¼ 5, 16%;). Recently, other species found to be associated with keratitis include N. transvalensis, which was reported to be resistant to amikacin [20]. Clinical features Nocardia keratitis generally runs a prolonged course. The usual presenting symptoms are pain, photophobia, blepharospasm, and lid swelling. The amount of pain may be out of proportion to the clinical findings [21]. The ulcer often has a gray, sloughing base and undermining overhanging necrotic edges [22]. Keratitis may be in the form of nonspecific punctate epitheliopathy or an ulcer with margins studded with yellow white discrete pinhead-sized superficial infiltration (Fig. 1) [23]. The infiltrates may be arranged in a ring-like fashion, forming the characteristic ‘wreath’ pattern (Fig. 2). Patchy infiltrates (Fig. 3), which are predominantly anterior stromal with associated involvement of epithelium and subepithelial tissues, are pathognomonic of Nocardia keratitis [2]. Satellite lesions may be associated [24,25]. The infiltrates are usually situated in the midperiphery of the cornea [2,26]. Usually, there Figure 1 Nocardia keratitis with superficial stromal infiltrates, with pinhead-like lesions but may also be mistaken for satellite lesions of mycotic keratitis N. asteroids keratitis has also been diagnosed following surgical trauma. Nascimento et al. [16] reported a case of N. asteroids keratitis following an uncomplicated myopic keratomileusis. Similarly, Perez-Santonja et al. [17] isolated Nocardia in a case presented as central interface nodule following uncomplicated laser-assisted in-situ keratomileusis retreatment for residual myopia. One case has been described following penetrating keratoplasty for Salzmann nodular degeneration [18]. Most Common causal agents Until recently, N. asteroids were the common species to be isolated from cases of keratitis. However, in recent times, advances in newer molecular techniques, including PCR restriction enzyme analysis and 16S ribosomal RNA sequencing, have shown that other species of Nocardia are more common. Copyright © Lippincott Williams & Wilkins. Unauthorized reproduction of this article is prohibited. CE: Namrta; ICU/334; Total nos of Pages: 6; ICU 334 Nocardia keratitis Lalitha 3 Figure 2 Nocardia keratitis with typical wreath pattern infiltrates found to have an indistinct fluffy or feather-like appearance with radiating projections. Nocardia keratitis may be associated with complications, which include progressive thinning leading to perforation, endophthalmitis, and extension to adjoining sclera [6]. Laboratory diagnosis Staining with modified acid-fast stains, and especially Gram stains, are important to provide rapid presumptive diagnosis while awaiting the results of the culture [28]. is an overlying epithelial defect. The surrounding stroma is usually clear [21]. Keratic precipitates and endothelial ring deposits seen on the endothelium are reported [27]. Anterior chamber reaction and hypopyon are usually associated [2,23]. Peripheral deep neovascularization extending to the cornea may be seen. The superficial granular infiltrates with time may coalesce into a white plaque and corneal ulceration may result. These classic presentations are manifest only when the patient present relatively early (within 2 weeks) [3]. The typical clinical appearance of Nocardia keratitis may prompt the clinician to the diagnosis. Even in situations in which the clinician either is not familiar with the clinical appearance or the presentation is atypical, microbiological investigations helps confirm the diagnosis. As treatment may be prolonged, it is important to have an exact diagnosis. Good communication between the treating physician and microbiologist is of utmost importance, especially to establish methods for obtaining and maintaining standard materials for collection, transport, and processing of samples. Routine laboratory diagnostic methods that are employed are very effective in identifying Nocardia organism. Bharathi et al. [15] found the sensitivity of KOH wet mount to be superior (100%) in the detection of Nocardia than that of Gram-stained smears (87%). Clinically, Nocardia keratitis may resemble mycotic keratitis or keratitis caused by atypical mycobacteria, which should be considered in the differential diagnosis [26]. Although mycotic keratitis is characterized by feathery edges, satellite lesions, and posterior cornel abscess, Nontuberculous Mycobacteria infections cause slowly progressive corneal infection and that infiltrate typically is Scraping from the corneal lesion is collected with the help of spatula or blade. Repeated scrapings need to be collected to make at least three smears and inoculate several culture media. The choice of media should encompass a wide range, allowing for the growth of all types of bacteria (aerobic, facultative anaerobic, and anaerobic), fungi, and Acanthamoeba [6]. Figure 3 Nocardia keratitis with patchy stromal infiltrates and larger hypopyon Processing of corneal scrapings Microscopic evaluation and culture are done on the corneal scrapping. Microscopic evaluation is a sensitive technique for the detection of Nocardia filaments Microscopic evaluation Smears are collected and usually stained by Gram stain, Giemsa stain, and KOH with calcofluor white stain and acid-fast stain using 1% sulfuric acid (modified Kinyoun’s method) and 10% KOH wet mount. Branching thin filaments can be seen in 10% KOH wet mount (Fig. 4). A corneal scraping smear that is positive for beaded Gram-positive, branching filaments (Fig. 5) and the presence of partially acid-fast branching filaments is highly suggestive of Nocardia sp. (Fig. 6). Branching at right angles is most often suggestive of N. asteroids. Demonstrating decolorization with 20% sulfuric acid Copyright © Lippincott Williams & Wilkins. Unauthorized reproduction of this article is prohibited. CE: Namrta; ICU/334; Total nos of Pages: 6; ICU 334 4 Corneal and external disorders Figure 4 Ten percent potassium hydroxide from direct smear of Nocardia keratitis showing filamentous fungi and Nocardia [Nocardia in italics] filaments in the same patient (x 450 magnification) Figure 6 Corneal scrapping stained with 1% acid-fast stain from an eye with Nocardia keratitis showing acid fast filaments Polymorphonuclear cells are also present. can differentiate it from mycobacteria. The cellular reaction observed in corneal scrapings is predominantly polymorphonuclear cells. Demonstration of typical filaments of Nocardia in corneal scrapings is sufficient indication for the initiation of specific antimicrobial therapy for Nocardia keratitis, especially in the presence of typical clinical features. Culture In culture, Nocardia organisms are not fastidious and grow aerobically in a variety of media without antibiotics. However, they tend to grow slowly. Dry colonies, usually Figure 5 Corneal scrapping stained with Gram’s stain from an eye with Nocardia keratitis showing Gram-positive, beaded, branching filaments (x 1250 magnification) tiny and white grow in 48–72 h on blood agar, chocolate agar, and Sabouraud’s Dextrose agar (without antibiotics). With prolonged incubation, they may appear waxy and hard or rough, with a velvety surface caused by rudimentary aerial mycelia. Colony coloration may vary from chalky white (Fig. 7), tan, buff, or yellow to orange. By 2–3 weeks, they may attain a size of 5–10 mm. Although the growth usually appears within 7 days, at least 2 weeks of inoculation may be required. Growth even on one medium is considered significant, especially with corresponding smear results and clinical picture. As Nocardia sp. is not a common contaminant of the external ocular surface or laboratory environment, their isolation is usually considered significant [6]. Smears from growth on laboratory media show coccoid and bacillary elements, which are Gram positive and resist decolorization by 1% sulfuric acid. Branching may or may not be seen. Clinical microbiology laboratories may not always be geared up to perform all tests for the species identification of Nocardia organisms. However, with regard to the treatment, speciation is not a critical requirement as a routine; only in rare instances, in which the ulcer is not responding to treatment. Antibiotic susceptibility tests In 2003, the Clinical and Laboratory Standards Institute published the first approved recommendations for antimicrobial susceptibility testing of aerobic actinomycetes, including Nocardia [29]. Although antibiotic susceptibility testing has been carried out routinely for Nocardia isolates from clinical samples, some factors that must be kept in mind are the relatively slow growth of the organism, difficulty in obtaining a smooth suspension Copyright © Lippincott Williams & Wilkins. Unauthorized reproduction of this article is prohibited. CE: Namrta; ICU/334; Total nos of Pages: 6; ICU 334 Nocardia keratitis Lalitha 5 Figure 7 Blood agar inoculated with corneal scrappings and incubated at 37{deg sign}C for 5 days showing heavy growth of small white dry colonies much lower than the sulphonamides when used to treat ocular nocardial infections [1]. Ever since, amikacin in the concentration of 2–2.5% is the treatment of choice in the monotherapy of Nocardia keratitis [24]. This concentration needs to be prepared from parenteral preparations of the drug. A case of Nocardia keratitis resistant to amikacin has been reported in literature [20]. It was treated successfully by adding 0.3% ciprofloxacin to the regimen. Many fluoroquinolones have emerged after the launch of ciprofloxacin. Third generation fluoroquinolones such as gatifloxacin and moxifloxacin have a spectrum of activity against most of the common ocular pathogens, including Nocardia [35]. Prajna et al. [36] have reported a case of nocardial sclerokeratitis that healed well with 0.02% polyhexamethylene biguanide, a swimming pool disinfectant used to treat Acanthamoeba keratitis. of the inoculum, pH, and type of agar used. Antibiotic susceptibility can be assessed by disc diffusion, broth dilution, and Epsilometer or E test methods. Different Nocardia strains vary in antibiotic sensitivity. Most Nocardia isolates are sensitive to sulfonamides such as sulfamethoxazole, trimethoprim–sulfamethoxazole, doxycycline, and amikacin. Newer diagnostic tools Reports have described the use of confocal laser microscopy as an in-vivo diagnostic tool. Vaddavalli et al. [30] examined three patients with microbiologically proven Nocardia keratitis with confocal microscopy and concluded that Nocardia, a filamentous bacterium, produces a distinct image on confocal microscopy. This in-vivo examination technique may be useful in cases of deepseated infiltrates in which routine microbiology workup does not yield positive result [30]. Molecular diagnosticbased methods such as the PCR are proving useful for both detection of Nocardia from the infected tissues as well as for species determination. PCR and PCR– restriction fragment length polymorphism molecular analysis (PRA, DNA sequencing, pyrosequencing, and ribotyping) [31,32]. Galor et al. [33] reported one case in which the new technology using pyrosequencing was used for the rapid species determination of Nocardia keratitis. The role of addition of systemic antibiotics is not very clear from the evidence in the literature. On the basis of the experience of treating our patients, systemic antibiotics really do not add any extra benefit in the outcome of Nocardia keratitis. Nocardia keratitis is quite amenable to medical treatment if the diagnosis is correct and treatment has been started early. In the study by Lalitha et al. [3] that correlated clinical presentation and treatment outcome of Nocardia keratitis with the time to diagnosis, different species and with the drug sensitivity pattern, it was found that the patients with Nocardia keratitis who presented within a 15-day period after the onset of the infection showed the highest recovery rate. It was also further found clinically that the ulcers were found to have a faster healing response in patients presenting early and combined with 2% amikacin treatment. In this series, only one patient needed therapeutic keratoplasty, and in one patient, the eye was enucleated. Ulcers healed in the majority of patients without vascularization. The surgical options are therapeutic lamellar keratectomy, penetrating keratoplasty, and conjunctival flap. Reports of surgically treated Nocardia keratitis are few and the outcome of surgical treatment was reported to be good in all these cases [3]. Conclusion Treatment of Nocardia keratitis Treatment of Nocardia keratitis is very prolonged. Since their discovery, sulphonamides were widely used to treat Nocardia in the early years. Sulphacetamide, sulphamethoxazole, and trimethoprim were considered to be the treatment of choice [34], until it was discovered that the minimum inhibitory concentrations of amikacin was The clinical presentation of Nocardia keratitis in the majority of instances is consistent with the typical description in the literature and is with patchy anterior stromal infiltrates and wreath pattern infiltrates in a patient with a history of ocular trauma. It is very important to alert the laboratory to look for the presence of Nocardia filaments in direct microscopy. Identification of thin, Gram-positive branching filaments, which are Copyright © Lippincott Williams & Wilkins. Unauthorized reproduction of this article is prohibited. CE: Namrta; ICU/334; Total nos of Pages: 6; ICU 334 6 Corneal and external disorders also 1% acid-fast staining positive is highly suggestive of Nocardia and treatment can be started. Treatment of choice in the current scenario is with topical fortified amikacin. Even though the treatment is prolonged, the infection responds well to treatment and resolves, forming a corneal scar. A high degree of suspicion, especially in areas endemic for Nocardia, aids in early diagnosis and initiation of treatment, which will decrease ocular morbidity. References and recommended reading Papers of particular interest, published within the annual period of review, have been highlighted as: of special interest of outstanding interest Additional references related to this topic can also be found in the Current World Literature section in this issue (pp. 000–000). 1 Sridhar MS, Sharma S, Garg P, Rao GN. Treatment and outcome of Nocardia keratitis. Cornea 2001; 20:458–462. 2 Sridhar MS, Sharma S, Reddy MK, et al. Clinicomicrobiological review of Nocardia keratitis. Cornea 1998; 17:17–22. 3 Lalitha P, Tiwari M, Prajna NV, et al. Nocardia keratitis: species, drug sensitivities, and clinical correlation. Cornea 2007; 26:255–259. This study describes the types of clinical presentation, correlation between the species of Nocardia associated with ulcers and antibiotic sensitivity, and the healing response in association with the species and with the antibiotics used over time. This study identified two new species of Nocardia. The important result of this study is that the characteristic clinical features and timely response to the appropriate treatment depended on early diagnosis and initiation of treatment. Nocardia ulcers in general have a good prognosis, but early referral and definite diagnosis by culture are essential to start specific therapy. 4 Hoffman PM, Poon A, Snibson GR. Nocardia keratitis in a contact lens wearer. Arch Ophthalmol 2005; 123:1759. 5 Patel NR, Reidy JJ, Gonzalez-Fernandez F. Nocardia keratitis after laser in situ keratomileusis: clinicopathologic correlation. J Cataract Refract Surg 2005; 31:2012–2015. 6 Sridhar MS, Gopinathan U, Garg P, et al. Ocular nocardia infections with special emphasis on the cornea. Surv Ophthalmol 2001; 45:361–378. 7 Brown-Elliott BA, Brown JM, Conville PS, Wallace R Jr. Clinical and laboratory features of the Nocardia spp. based on current molecular taxonomy. Clin Microbiol Rev 2006; 19:259–282. 8 9 Brown JM, McNeil MM, Desmond EP. Nocardia, Rhodococcus, Gordona, Actinomadura, Streptomyces and other Actinomycetes of medical importance. In: Murray PR, editor. Manual of clinical microbiology, 7th ed. Washington District of Columbia: American Society of Microbiology Press; 2005 . p. 370. Couble A, Rodriguez-Nava V, Montclos MP, et al. Direct detection of Nocardia spp. in clinical samples by a rapid molecular method. J Clin Microbiol 2005; 43:1921–1924. 10 Laurent FJ, Provost F, Boiron P. Rapid identification of clinically relevant Nocardia species to genus level by 16S rRNA gene PCR. J Clin Microbiol 1999; 37:99–102. 13 Garg P, Rao GN. Corneal ulcer: diagnosis, treatment and prevention. Community Eye Health 1999; 12:21–23. 14 Srinivasan M, Gonzales CA, George C, et al. Epidemiology and etiological diagnosis of corneal ulceration in Madurai, South India. Br J Ophthalmol 1997; 81:965–971. 15 Bharathi MJ, Ramakrishnan R, Vasu S, et al. Nocardia asteroids keratitis in South India. Indian J Med Microbiol 2003; 21:31–36. 16 Nascimento EG, Carvalho MJ, de Freitas D, Campos M. Nocardia keratitis following myopic keratomileusis. J Refract Surg 1995; 11:510–511. 17 Perez-Santonja JJ, Sakla HF, Abad JL, et al. Nocardial keratitis after laser in situ keratomileusis. J Refract Surg 1997; 13:314–317. 18 Colomina J, Esparza L, Buesa J, Mari J. Corneal ulcer caused by Nocardia asteroids after penetrating keratoplasty. Med Clin (Barc) 1997; 108:424– 425. 19 Yin X, Liang S, Sun X, et al. Ocular nocardiosis: HSP65 gene sequencing for species identification of Nocardia spp. Am J Ophthalmol 2007; 144:570– 573. This study describes novel methods of Nocardia identification from ocular infection. 20 Pandya VB, Petsoglou C. Nocardia transvalensis resistant to amikac: an unusual cause of microbial keratitis. Cornea 2008; 27:1082–1085. 21 Parsons MR, Holland EJ, Agapitos PJ. Nocardia asteroids keratitis associated with extended-wear soft contact lenses. Can J Ophthalmol 1989; 24:120– 122. 22 Duke-Elder S, Heigh AG. Systems of ophthalmology: diseases of the outer eye, vol. 8. St. Louis: Mosby; 1965. p. 790. 23 Srinivasan M, Sharma S. Nocardia keratitis as a cause of corneal ulcer. Arch Ophthalmol 1987; 105:464. 24 Denk PO, Thanos S, Thiel HJ. Amikacin may be drug of choice in Nocardia keratitis [letter]. Br J Ophthalmol 1996; 80:928–929. 25 Tendolkar UM, Varaiya A, Ahuja AS, et al. Corneal ulcer caused by Nocardia asteroids in a patient with leprosy [published erratum appears in J Clin Microbiol 1999; 37: 2392] [see comments]. J Clin Microbiol 1998; 36:1154– 1156. 26 Huang AJW, Pflugfelder SC. Nocardial and actinomycotic keratitis. In: Pepose JS, Holland GN, Wilhelmus KR, editors. Ocular Infection and immunity. St. Louis: Mosby; 1996. pp. 1043–1047. 27 Hirst LW, Merz WG, Green WR. Nocardia asteroids corneal ulcer [letter]. Am J Ophthalmol 1982; 94:123–124. 28 Saubolle MA, Sussland D. Nocardiosis: review of clinical and laboratory experience. J Clin Microbiol 2003; 41:4497–4501. 29 NCCLS. Susceptibility testing of mycobacteria, nocardiae, and other aerobic actinomycetes. Approved standard. NCCLS document M24-A. Wayne, Pennsylvania: NCCLS. 30 Vaddavalli PK, Garg P, Sharma S, et al. Confocal microscopy for Nocardia keratitis. Ophthalmology 2006; 113:1645–1650. 31 Brown JM, Pham KN, McNeil MM, Lasker BA. Rapid identification of Nocardia farcinica clinical isolates by a PCR assay targeting a 314-base-pair speciesspecific DNA fragment. J Clin Microbiol 2004; 42:3655–3660. 32 Patel JB, Wallace RJ Jr, Brown-Elliott BA, et al. Sequence-based identification of aerobic actinomycetes. J Clin Microbiol 2004; 42:2530–2540. 33 Galor A, Hall GS, Procop GW, et al. Rapid species determination of Nocardia keratitis using pyrosequencing technology. Am J Ophthalmol 2007; 143:182–183. 34 Lee LH, Zaidman GW, Van Horn K. Topical Bactrim versus trimethoprim and sulphonamide against nocardia keratitis. Cornea 2001; 20:179–182. 11 Rodrı´guez-Nava V, Couble A, Devulder G, et al. Use of PCR-restriction enzyme pattern analysis and sequencing database for hsp65 gene-based identification of Nocardia species. J Clin Microbiol 2006; 44:536–546. 35 Callegan MC, Ramirez R, Kane ST, et al. Antibacterial activity of the fourthgeneration fluoroquinolones gatifloxacin and moxifloxacin against ocular pathogens. Adv Ther 2003; 20:246–252. 12 Upadhyay MP, Karmacharya PC, Koirala S, et al. Epidemiologic characteristics, predisposing factors, and etiologic diagnosis of corneal ulceration in Nepal. Am J Ophthalmol 1991; 111:92–99. 36 Prajna NV, Anitha M, Divya E, et al. Effects of topical 0.02% PHMB on Nocardia keratitis associated with scleritis. Indian J Ophthalmol 1998; 46:251–252. Copyright © Lippincott Williams & Wilkins. Unauthorized reproduction of this article is prohibited.